rethinkTHC Search
Menu
Study breakdown

CBD as a Harm Reduction Tool for People Who Use Drugs

evidence
The takeaway

A rapid review found emerging evidence supporting CBD as a potential harm reduction strategy for people with problematic substance use, though more research is needed.

Harm reduction workers, addiction medicine specialists, public health policymakers, and people who use drugs.

Novel harm reduction

Emerging evidence supports CBD as a potential harm reduction strategy for problematic substance use

What the researchers found

Emerging evidence suggests CBD may have utility as a harm reduction modality for people with problematic substance use, with potential applications in reducing cravings, withdrawal symptoms, and substance use across multiple drug categories.

Why it matters

The drug poisoning crisis across North America demands novel harm reduction approaches, and CBD represents an accessible, low-risk intervention that could complement existing strategies.

The numbers in context

The rapid review synthesized available evidence on CBDs potential as a harm reduction strategy during the North American drug poisoning crisis.

How the study worked

Rapid review synthesizing evidence on CBD as a harm reduction modality for problematic substance use.

Who was studied

People who use drugs with problematic substance use patterns.

What this study cannot tell us

Rapid review format may miss relevant studies; evidence base is still small; most studies are preliminary; CBD product quality and dosing vary widely.

How to read the evidence

Rapid review of emerging evidence; most underlying studies are preliminary, limiting confidence.

When this study was published

Recent review responding to the ongoing drug poisoning crisis.

The bigger picture

Positioning CBD within harm reduction frameworks represents a pragmatic approach that meets people where they are, rather than requiring abstinence as a precondition for support.

Replication

Emerging field; rapid review format provides initial synthesis of a growing evidence base.

Funding

Not specified

Conflicts of interest

Not specified

Questions still open

  • Which substances does CBD show most promise for?
  • What CBD doses and formulations are most effective for harm reduction?
  • How do harm reduction organizations view CBDs role?

Read the original research

Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 68(8), 557-571

Citation

Lo, Lindsay A; MacCallum, Caroline A; Nanson, Kate; Koehn, Michael; Mitchell, Ian; Milloy, Michael-John; Walsh, Zach; Fehr, Florriann. (2023). Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review.. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 68(8), 557-571. https://doi.org/10.1177/07067437231183525